Repligen RGEN
NASDAQ RGEN
$181.13 +0.84 (+0.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Repligen (RGEN) EBT Margin Growth (3y) (2013 - 2026)

Repligen (RGEN) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 803.00
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 146.00
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -1,042.00
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 773.00
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -388.00
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -1,500.00
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -1,195.00
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 1,240.00
10 Repligen 10.25 Bn 9.24 Bn 110.04 Mn -871.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.00
Mar 31, 2026 -1,031.00
Dec 31, 2025 -683.00
Sep 30, 2025 -1,458.00
Jun 30, 2025 -1,879.00
Mar 31, 2025 -2,386.00
Dec 31, 2024 -7,890.00
Sep 30, 2024 -2,388.00
Jun 30, 2024 -2,154.00
Mar 31, 2024 -2,076.00
Dec 31, 2023 245.00
Sep 30, 2023 -1,080.00
Jun 30, 2023 -267.00
Mar 31, 2023 -281.00
Dec 31, 2022 2,212.00
Sep 30, 2022 2,124.00
Jun 30, 2022 1,517.00
Mar 31, 2022 1,121.00
Dec 31, 2021 545.00
Sep 30, 2021 976.00